Dr. Ann Partridge on Aggressive Breast Cancer in Younger Women
Partridge says that the current school of thought is younger women should be treated the same as older women with breast cancer, though younger women tend to develop more aggressive breast cancer with more nodal involvement.
Ann Partridge, MD, MPH, breast medical oncologist, Dana-Farber Cancer Institute, discusses the treatment of young women with breast cancer versus older women with breast cancer. Partridge says that the current school of thought is younger women should be treated the same as older women with breast cancer, though younger women tend to develop more aggressive breast cancer with more nodal involvement. Partridge says this is likely due to them not undergoing screening the same as older women with breast cancer.
Roundtable Roundup: Adjuvant Therapy for HR+, HER2- Breast Cancer
June 17th 2025In separate, live virtual events, William J. Gradishar, MD; and Tiffany A. Traina, MD, discussed multiple scenarios for a patient with hormone receptor–positive, HER2-negative breast cancer to potentially receive hormonal plus endocrine therapy.
Read More
